NCT04252521View on ClinicalTrials.gov

Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
Migraine
Interventions
DRUG

metoclopramide

10 mg Metpamid in 100 ml normal saline solution

DRUG

dexketoprofen trometamol

50 mg dexketoprofen trometamol in 100 ml normal saline solution

DRUG

metoclopramide+dexketoprofen trometamol

10 mg metoclopramide+50 mg dexketoprofen trometamol in 100 ml normal saline solution

Trial Locations (1)

02000

Adiyaman University Research Hospital, Adıyaman

All Listed Sponsors
lead

Adiyaman University Research Hospital

OTHER

NCT04252521 - Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine | Biotech Hunter | Biotech Hunter